157 related items for PubMed ID: 21914315
1. [Evaluation of shensongyangxin capsules in the treatment of paroxysmal atrial fibrillation: a randomized, double-blind and controlled multicenter trial].
Wang AH, Pu JL, Qi XY, Miao WL, Hou ZS, Cong HL, Zhou JZ, Liu XF, Li SM, Han QH, Liu YJ, Yang XC.
Zhonghua Yi Xue Za Zhi; 2011 Jun 28; 91(24):1677-81. PubMed ID: 21914315
[Abstract] [Full Text] [Related]
2. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study].
Lardoux H, Maison Blanche P, Marchand X, Canler A, Rouesnel P, Bleinc D, Péraudeau P, Scheck F.
Ann Cardiol Angeiol (Paris); 1996 Oct 28; 45(8):469-79. PubMed ID: 8952741
[Abstract] [Full Text] [Related]
3. [Propafenone and sotalol: long-term efficacy and tolerability in the prevention of paroxysmal atrial fibrillation. A placebo-controlled double-blind study].
Bellandi F, Dabizzi RP, Niccoli L, Cantini F, Palchetti R.
G Ital Cardiol; 1996 Apr 28; 26(4):379-90. PubMed ID: 8707022
[Abstract] [Full Text] [Related]
4. [Immediate cardioversion of atrial fibrillation and atrial flutter lasting less than 90 days by ibutilide versus propafenone: a multicenter study].
Zhang HC, Guo JH, Fang Q, Zheng YA, Sun YM, Zhu WQ, Wan Z, Guo JX, Ge JB, Han SM.
Zhonghua Yi Xue Za Zhi; 2005 Mar 30; 85(12):798-801. PubMed ID: 15949393
[Abstract] [Full Text] [Related]
5. A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. UK Propafenone PSVT Study Group.
Circulation; 1995 Nov 01; 92(9):2550-7. PubMed ID: 7586356
[Abstract] [Full Text] [Related]
6. Comparisons of oral propafenone and quinidine as an initial treatment option in patients with symptomatic paroxysmal atrial fibrillation: a double-blind, randomized trial.
Lee SH, Chen SA, Chiang CE, Tai CT, Wen ZC, Wang SP, Chang MS.
J Intern Med; 1996 Mar 01; 239(3):253-60. PubMed ID: 8772625
[Abstract] [Full Text] [Related]
7. [Efficacy of intravenous Acehytisine Hydrochloride versus propafenone on terminating paroxysmal supraventricular tachycardia: a double-blinded, randomized multi-center study].
Gao X, Zhu J, Yang YM, Li JD, Yang ZM, Liu JH, Acehytisine Hydrochloride Injection Phase II Clinic Trial Group Investigators.
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Feb 01; 35(2):151-4. PubMed ID: 17445412
[Abstract] [Full Text] [Related]
8. [Effect of shensongyangxin capsule on myocardial remodeling and ventricular fibrillation threshold value in rat with coronary artery ligation].
Chai S, Wang S, Yao L, Wu A, Liu Y, Rao C.
Zhongguo Zhong Yao Za Zhi; 2009 Aug 01; 34(16):2101-4. PubMed ID: 19938556
[Abstract] [Full Text] [Related]
9. [Effectiveness and side effects of the treatment with propafenone and flecainide for recent-onset atrial fibrillation].
Romano S, Fattore L, Toscano G, Corsini F, Coppo A, Catanzaro M, Romano A, Martone A, Caccavale F, Iodice E, Di Maggio O, Corsini G.
Ital Heart J Suppl; 2001 Jan 01; 2(1):41-5. PubMed ID: 11216083
[Abstract] [Full Text] [Related]
10. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators.
Roy D, Talajic M, Dorian P, Connolly S, Eisenberg MJ, Green M, Kus T, Lambert J, Dubuc M, Gagné P, Nattel S, Thibault B.
N Engl J Med; 2000 Mar 30; 342(13):913-20. PubMed ID: 10738049
[Abstract] [Full Text] [Related]
11. [Comparison of efficacy, safety and cost-effectiveness of intravenous versus oral propafenone in paroxysmal atrial fibrillation].
Zadura M, Grossmann G, Modrzewska A, Klecha T, Klepacka H, Rumiński W.
Pol Merkur Lekarski; 2001 Aug 30; 11(62):137-9. PubMed ID: 11757212
[Abstract] [Full Text] [Related]
12. Comparison of the safety and efficacy of flecainide versus propafenone in hospital out-patients with symptomatic paroxysmal atrial fibrillation/flutter. The Flecainide AF French Study Group.
Aliot E, Denjoy I.
Am J Cardiol; 1996 Jan 25; 77(3):66A-71A. PubMed ID: 8607394
[Abstract] [Full Text] [Related]
13. Propafenone for the prevention of atrial tachyarrhythmias after cardiac surgery: a randomized, double-blind placebo-controlled trial.
Mörike K, Kivistö KT, Schaeffeler E, Jägle C, Igel S, Drescher S, Fux R, Marx C, Hofmann U, Engel C, Wagner F, Delabar U, Meisner C, Bail D, Böhm JO, Gleiter CH, Ziemer G, Rein JG, Hellberg KD, Eichelbaum M, Schwab M.
Clin Pharmacol Ther; 2008 Jul 25; 84(1):104-10. PubMed ID: 18167502
[Abstract] [Full Text] [Related]
14. Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket" approach.
Alboni P, Botto GL, Baldi N, Luzi M, Russo V, Gianfranchi L, Marchi P, Calzolari M, Solano A, Baroffio R, Gaggioli G.
N Engl J Med; 2004 Dec 02; 351(23):2384-91. PubMed ID: 15575054
[Abstract] [Full Text] [Related]
15. [Comparison of anti-arrhythmic therapy guided by the transesophageal electropharmacologic test and emperic therapy in the prophylaxis of atrial fibrillation recurrence].
Fera MS, Carunchio A, Burattini M, Mazza A, Coletta C, Galati A, Ceci V.
G Ital Cardiol; 1997 Feb 02; 27(2):152-63. PubMed ID: 9244718
[Abstract] [Full Text] [Related]
16. Intravenous versus oral initial load of propafenone for conversion of recent-onset atrial fibrillation in the emergency room: a randomized trial.
Madonia S, De Simone M, Brai G, Gozzo D, Gristina A, Luciano L, Maisano S, Migliore G, Mineo R, Muzzo MP, Nicchi F, Randazzo A, Raspanti G, Rotolo G, Russo A, Sagona F, Schirosa M, Spinello M, Stancampiano R, Geraci E.
Ital Heart J; 2000 Jul 02; 1(7):475-9. PubMed ID: 10933330
[Abstract] [Full Text] [Related]
17. Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter.
Chiladakis JA, Kalogeropoulos A, Patsouras N, Manolis AS.
J Am Coll Cardiol; 2004 Aug 18; 44(4):859-63. PubMed ID: 15312872
[Abstract] [Full Text] [Related]
18. Efficacy and tolerability of oral propafenone versus quinidine in the treatment of recent onset atrial fibrillation: A randomized, prospective study.
Kosior DA, Kochanowski J, Scisło P, Piatkowski R, Postuła M, Rabczenko D, Opolski G.
Cardiol J; 2009 Aug 18; 16(6):521-7. PubMed ID: 19950088
[Abstract] [Full Text] [Related]
19. Efficacy and safety of propafenone sustained release in the prophylaxis of symptomatic paroxysmal atrial fibrillation (The European Rythmol/Rytmonorm Atrial Fibrillation Trial [ERAFT] Study).
Meinertz T, Lip GY, Lombardi F, Sadowski ZP, Kalsch B, Camez A, Hewkin A, Eberle S, ERAFT Investigators.
Am J Cardiol; 2002 Dec 15; 90(12):1300-6. PubMed ID: 12480038
[Abstract] [Full Text] [Related]
20. [Propafenone dose for emergency room conversion of paroxysmal atrial fibrillation].
Antonelli D, Darawsha A, Rimbrot S, Freedberg NA, Rosenfeld T.
Harefuah; 1999 Jun 01; 136(11):857-9, 915. PubMed ID: 10955129
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
